• Ibotenic Acid in Neural Circuit Mapping: Precision for Trans

  2026-04-30

  Explore how ibotenic acid, a potent NMDA receptor agonist, enables high-fidelity interrogation of brain-to-spinal pain circuits and advanced neurodegenerative disease modeling. This article uniquely bridges recent circuit-level insights with optimized assay strategies for translational neuroscience.

• ECM1 Drives Anti-Androgen Resistance in Bone Metastatic Pros

  2026-04-30

  This study uncovers how osteoblast-derived ECM1 triggers resistance to enzalutamide in bone metastatic prostate cancer. By elucidating a novel ECM1–ENO1–MAPK signaling axis, it highlights new potential therapeutic targets for overcoming anti-androgen resistance in advanced prostate cancer.

• Improving In Vitro Cancer Drug Response Evaluation: Insights

  2026-04-29

  Schwartz et al. (2022) critically dissect how current in vitro methods assess anti-cancer drug responses, distinguishing the often conflated effects of proliferative inhibition and cell death. Their work clarifies measurement nuances and provides a framework for more precise preclinical drug evaluation.

• Glabridin-Gold(I) Complex 6d: Synergistic Immunomodulation i

  2026-04-29

  This study introduces a novel glabridin-gold(I) complex (6d) that targets both thioredoxin reductase (TrxR) and MAPK pathways to enhance antitumor immunity in liver cancer. The dual-action mechanism of 6d demonstrates significant potential for overcoming immunosuppressive barriers in the tumor microenvironment, suggesting new avenues for combination cancer immunotherapy.

• Dextran Sulfate Sodium Salt (MW 35000-45000): Illuminating C

  2026-04-28

  Explore how Dextran sulfate sodium salt (MW 35000-45000) enables precise modeling of intestinal barrier damage and epithelial repair in ulcerative colitis research. Uncover new insights into assay design, leveraging recent mechanistic breakthroughs to advance translational IBD studies.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-04-28

  Anlotinib hydrochloride is a potent, orally bioavailable multi-target tyrosine kinase inhibitor with robust anti-angiogenic activity. It selectively inhibits VEGFR2, PDGFRβ, and FGFR1 with nanomolar potency and demonstrates superior efficacy in endothelial cell migration inhibition and capillary tube formation assays. This article outlines its mechanism, benchmarks, and best-practice applications for cancer research.

• CORE LNPs Enable Spleen-Targeted mRNA Delivery via Cholester

  2026-04-27

  The referenced study introduces a new class of lipid nanoparticles (CORE LNPs) with modified cholesterol analogs that redirect mRNA expression from the liver to the spleen after systemic administration. This approach offers a platform for spleen-specific mRNA therapies, with implications for vaccine and immune modulation applications.

• Cyclic Pifithrin-α Hydrobromide: Decoding p53 Inhibition in

  2026-04-27

  Explore the multifaceted utility of Cyclic Pifithrin-α hydrobromide as a p53 inhibitor, with a special focus on neuroinflammation and radioprotection. This in-depth analysis reveals novel mechanistic insights and practical guidance for advanced research applications.

• G-15 in Osteoblast Signaling: Dissecting GPR30 Antagonism fo

  2026-04-26

  Explore how G-15, a selective G protein-coupled estrogen receptor antagonist, empowers targeted estrogen signaling research in osteoblast models. This article uniquely bridges advanced mechanistic insight with protocol guidance for bone biology, setting it apart from existing coverage.

• Miltefosine Promotes Neutrophil Differentiation via Ras/MEK/

  2026-04-25

  A recent study reveals that miltefosine, or hexadecyl 2-(trimethylazaniumyl)ethyl phosphate, stimulates neutrophil differentiation and function by activating the Ras/MEK/ERK pathway. These findings offer a mechanistic advance for addressing leukopenia, with implications for translational hematology and future therapeutic approaches.

• Clozapine in Schizophrenia Research: Protocols & Innovation

  2026-04-24

  Clozapine, a trusted atypical antipsychotic medication from APExBIO, enables precise interrogation of neuropharmacological pathways in schizophrenia models. This guide delivers actionable protocols, troubleshooting tactics, and translational insights, integrating novel findings on synaptic modulation to elevate your experimental workflow.

• DiscoveryProbe FDA-approved Drug Library: Evidence and Proto

  2026-04-24

  The DiscoveryProbe FDA-approved Drug Library (SKU: L1021) by APExBIO is a rigorously curated, pre-dissolved collection of 2,320 clinically approved compounds, optimized for high-content and high-throughput drug screening. Its regulatory scope and validated mechanisms make it a premier resource for drug repositioning, pharmacological target identification, and translational research. This article details its composition, benchmarking evidence, and optimal workflow integration.

• Palomid 529: Applied PI3K/Akt/mTOR Inhibition in Cancer Rese

  2026-04-23

  Palomid 529 (P529) delivers precise, dual mTORC1/mTORC2 inhibition, enabling researchers to dissect mechanisms of metastasis, chemoresistance, and angiogenesis in cancer models. This workflow-oriented guide details optimized protocols, troubleshooting strategies, and the practical impact of targeting the PI3K/Akt/mTOR pathway with P529.

• Monomethyl Auristatin E: Protocol Enhancements in ADC Cancer

  2026-04-23

  Monomethyl auristatin E (MMAE) is a gold-standard payload in antibody-drug conjugate (ADC) workflows, prized for its sub-nanomolar potency and reliability in targeted cancer therapy. This guide dissects MMAE’s application from bench to preclinical xenograft models, offering actionable troubleshooting and protocol calibration for maximal translational impact.

• Perphenazine: Dopamine D2 Antagonist in Advanced Research Wo

  2026-04-22

  Perphenazine stands out as a versatile dopamine D2 receptor antagonist, combining validated roles in neuropharmacology with emerging applications in host-directed antibacterial strategies. This comprehensive guide delivers actionable workflows, protocol parameters, and troubleshooting tips, empowering researchers to leverage Perphenazine for mitochondria-mediated cell death induction, opioid tolerance suppression, and beyond.

15932 records 1/1063 page Next 12345 下5页 Last page